BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220718T080000
DTEND;TZID=America/Toronto:20220720T150000
DTSTAMP:20260427T124410
CREATED:20220526T183903Z
LAST-MODIFIED:20220706T002822Z
UID:20181-1658131200-1658329200@scienceinboston.com
SUMMARY:LEAP HR: Life Sciences East 2022
DESCRIPTION:LEAP HR: Life Sciences East is an opportunity to spend two days stepping inside 30+ case studies of how established and emerging life sciences organizations operating on the East Coast and surrounding areas are breaking away from traditional HR to seize the new opportunities that will inspire the talent they need to drive mission-critical innovation. \nGain access to the HR innovation that is truly making a difference to employees\, patients and customers – and leave with a brand-new playbook for the people function to thrive in the evolving workplace environments of life sciences organizations on the East Coast and surrounding areas.
URL:https://scienceinboston.com/event/leap-hr-life-sciences-east-2022/
LOCATION:Hilton Boston Logan Airport\, One Hotel Drive\, Boston\, 02128\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220718T080000
DTEND;TZID=America/Toronto:20220720T150000
DTSTAMP:20260427T124410
CREATED:20220526T183903Z
LAST-MODIFIED:20220526T183903Z
UID:27839-1658131200-1658329200@scienceinboston.com
SUMMARY:LEAP HR: Life Sciences East 2022
DESCRIPTION:LEAP HR: Life Sciences East is an opportunity to spend two days stepping inside 30+ case studies of how established and emerging life sciences organizations operating on the East Coast and surrounding areas are breaking away from traditional HR to seize the new opportunities that will inspire the talent they need to drive mission-critical innovation. \nGain access to the HR innovation that is truly making a difference to employees\, patients and customers – and leave with a brand-new playbook for the people function to thrive in the evolving workplace environments of life sciences organizations on the East Coast and surrounding areas.
URL:https://scienceinboston.com/event/leap-hr-life-sciences-east-2022-2/
LOCATION:Hilton Boston Logan Airport\, One Hotel Drive\, Boston\, 02128\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220719T080000
DTEND;TZID=America/Toronto:20220719T100000
DTSTAMP:20260427T124410
CREATED:20220705T161746Z
LAST-MODIFIED:20220705T161746Z
UID:20676-1658217600-1658224800@scienceinboston.com
SUMMARY:Turning Great Ideas into Dollars: The Life-Cycle of a Start-Up - Part Two
DESCRIPTION:Funding your Start-up\, Ideas and Strategies: Time to Kiss all the Frogs!\nJoin us for the second event of a three-part series exploring the best approach for independent early-stage entrepreneurs and biotechs to get funding at various stages. \nNot all funding is created equal! Join this forum discussion to hear from our experts on the various avenues to fund your startup\, friends and family\, golden tickets\, competitions\, mentor groups\, all will be covered. We will also discuss how to be prepared when its time to ask for funding.
URL:https://scienceinboston.com/event/turning-great-ideas-into-dollars-the-life-cycle-of-a-start-up-part-two/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220719T080000
DTEND;TZID=America/Toronto:20220719T100000
DTSTAMP:20260427T124410
CREATED:20220705T161746Z
LAST-MODIFIED:20220705T161746Z
UID:27850-1658217600-1658224800@scienceinboston.com
SUMMARY:Turning Great Ideas into Dollars: The Life-Cycle of a Start-Up - Part Two
DESCRIPTION:Funding your Start-up\, Ideas and Strategies: Time to Kiss all the Frogs!\nJoin us for the second event of a three-part series exploring the best approach for independent early-stage entrepreneurs and biotechs to get funding at various stages. \nNot all funding is created equal! Join this forum discussion to hear from our experts on the various avenues to fund your startup\, friends and family\, golden tickets\, competitions\, mentor groups\, all will be covered. We will also discuss how to be prepared when its time to ask for funding.
URL:https://scienceinboston.com/event/turning-great-ideas-into-dollars-the-life-cycle-of-a-start-up-part-two-2/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220726T080000
DTEND;TZID=America/Toronto:20220728T170000
DTSTAMP:20260427T124410
CREATED:20220719T164608Z
LAST-MODIFIED:20220719T164608Z
UID:20879-1658822400-1659027600@scienceinboston.com
SUMMARY:iPSC Manufacturing Summit
DESCRIPTION:Join us in Boston for the iPSC Manufacturing Summit\, the only forum dedicated to optimizing the scalable manufacture of high-quality and consistent iPSCs. \nCapture the unmatched potential of these versatile stem cells in regenerative medicine and cell therapy by advancing scale-up\, differentiation and quality to reduce variability and ensure stable and robust cell lines. \nGain valuable insights from industry experts\, through exclusive talks and discussions\, into approaches to transform your manufacturing processes by exploring technology innovations\, leveraging automation and AI\, evolving analytics and advancing cryopreservation.
URL:https://scienceinboston.com/event/ipsc-manufacturing-summit/
LOCATION:The Bostonian\, 26 North St\, Boston\, MA\, 02109\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220726T080000
DTEND;TZID=America/Toronto:20220728T170000
DTSTAMP:20260427T124410
CREATED:20220719T164608Z
LAST-MODIFIED:20220719T164608Z
UID:27854-1658822400-1659027600@scienceinboston.com
SUMMARY:iPSC Manufacturing Summit
DESCRIPTION:Join us in Boston for the iPSC Manufacturing Summit\, the only forum dedicated to optimizing the scalable manufacture of high-quality and consistent iPSCs. \nCapture the unmatched potential of these versatile stem cells in regenerative medicine and cell therapy by advancing scale-up\, differentiation and quality to reduce variability and ensure stable and robust cell lines. \nGain valuable insights from industry experts\, through exclusive talks and discussions\, into approaches to transform your manufacturing processes by exploring technology innovations\, leveraging automation and AI\, evolving analytics and advancing cryopreservation.
URL:https://scienceinboston.com/event/ipsc-manufacturing-summit-2/
LOCATION:The Bostonian\, 26 North St\, Boston\, MA\, 02109\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220802T110000
DTEND;TZID=America/Toronto:20220802T114500
DTSTAMP:20260427T124410
CREATED:20220627T202034Z
LAST-MODIFIED:20220627T202034Z
UID:20627-1659438000-1659440700@scienceinboston.com
SUMMARY:American Heart Association Funding Webinar
DESCRIPTION:Learn about upcoming AHA Research award offerings\, application tips\, and the review process. Each webinar will consist of a 20-minute overview of the AHA Research award offerings\, plus a 10-minute Q & A session. These calls are a great opportunity for scientists\, researchers\, institutions\, and grant officers to get application questions answered.
URL:https://scienceinboston.com/event/american-heart-association-funding-webinar/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220802T110000
DTEND;TZID=America/Toronto:20220802T114500
DTSTAMP:20260427T124410
CREATED:20220627T202034Z
LAST-MODIFIED:20220627T202034Z
UID:27849-1659438000-1659440700@scienceinboston.com
SUMMARY:American Heart Association Funding Webinar
DESCRIPTION:Learn about upcoming AHA Research award offerings\, application tips\, and the review process. Each webinar will consist of a 20-minute overview of the AHA Research award offerings\, plus a 10-minute Q & A session. These calls are a great opportunity for scientists\, researchers\, institutions\, and grant officers to get application questions answered.
URL:https://scienceinboston.com/event/american-heart-association-funding-webinar-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220802T120000
DTEND;TZID=America/Toronto:20220802T130000
DTSTAMP:20260427T124410
CREATED:20220729T181012Z
LAST-MODIFIED:20220729T181029Z
UID:21012-1659441600-1659445200@scienceinboston.com
SUMMARY:Aging Brain Seminar with Hideyuki Okano
DESCRIPTION:*This seminar will be held in-person in MIT Building 46\, Room 46-3310 (Picower Seminar Room). If you are attending from outside of MIT\, please email Brittany Greenough at bgreeno@mit.edu to be issued a ticket to gain entry to the building.* \nTalk Title: Modeling neurological diseases using iPS cell technologies and genetically modified non-human primates \nAbstract: The investigation of human neurological/psychiatric disorders have been difficult based on the following reasons: i) Diseases Model Mice do not always recapitulate the pathophysiology of human diseases. ii) Genotype-Phenotype causal relationships are not always clear in many human neurological and psychiatric disorders. iii) It is extremely difficult to investigate what is taking place in vivo at the onset of the disease. iv) The low accessibility to the pathological foci in the human brain. v) The neuronal circuits responsible for the disease phenotypes are mostly unidentified. To overcome these\, we are taking advantage of Take the Advantage of iPS cell technology and genetically modified non-human primates. \nHuman iPS cell (iPSC)-based techniques offer new opportunities for disease modeling and the development of new drugs\, especially for conditions such as neurological and psychiatric diseases in which access to the affected cells and pathogenic sites is limited. So far\, we have established patient-specific iPSCs from more than 40 neurological and psychiatric diseases\, including amyotrophic lateral sclerosis (ALS)\, Alzheimer’s disease\, Parkinson’s disease\, and so on. Today\, I am going to focus on the iPSCs-based investigation of ALS\, which is a devastating neurodegenerative disease characterized by loss of upper motor neurons (MNs) and/or lower MNs (LMNs). Using iPSCs-MNs derived from familial ALS patients with FUS and TDP-43 mutations\, we could identify Ropinirole (ROPI: Already approved as an anti-PD drug with D2R agonist) as a potential anti-ALS Drug which is further being investigated as a clinical trial (ROPALS trial). As a result of the ROPALS trial\, we conclude that ROPI is a safe and effective drug for ALS patients. ROPI significantly suppressed the progression of ALS and prolonged the time to respiratory failure over the 1-year treatment period. This clinical trial proved that iPS cell drug discovery was useful as a new drug screening tool. \nThe common marmoset (Callithrix jacchus) is a small New World primate that has been extensively used in biomedical research models. There is also an increasing interest in common marmoset in Brain Science and as appropriate models for major human brain disorders (Okano\, Annual Rev Neurosci\, 2021). We succeeded in generating the world’s first genetically modified (GM) marmoset with germline transmission by lentiviral mediated transgenesis (Sasaki et al.\, Nature\, 2009) and genome-edited marmosets (GM) (Sato et al.\, Cell Stem Cell\, 2016). I wish to mention our recent data on the generation of transgenic marmoset models of neurodegenerative diseases\, including Parkinson’s disease (PD) which overexpressed the mutant form of a-synuclein using a lentiviral vector. The PD model marmoset showed stage-dependent progression of the disease\, such as sleeping disturbance followed by the motor deficit. In addition\, I will mention a model marmoset of a neurodevelopmental disorder\, the Rett syndrome\, obtained by genome editing of MECP2 gene. Abnormalities in brain structure and function in these marmoset models may accelerate the discovery of disease biomarkers and mechanisms for translation. \nBio: Hideyuki Okano received his M.D. in Physiology from Keio University in 1983. After he obtained a Ph.D. degree in Molecular Biology of Myelin-related genes and myelin deficient mutant mice from Keio University in 1988\, he held a post-doctoral position at Dr. Craig Montell’s Lab at Johns Hopkins University School of Medicine. He was appointed full professor at Tsukuba University School of Medicine in 1994\, Osaka University School of Medicine in 1997\, and returned to Keio University Medical School in 2001 as a full professor of Physiology. Since 2007\, he has been a Dean of Keio University Graduate School of Medicine or a Dean of Keio University School of Medicine. He has been conducting basic research in the field of regenerative medicine including\, neural stem cells and iPS cells\, spinal cord injury\, developmental genetics\, and RNA binding proteins. He has been awarded a number of awards and honors including the Medal with Purple Ribbon in 2009\, the first prize of the 51st Erwin von Bälz Prize in 2014\, the 18th Takamine Memorial Daiichi Sankyo Prize in 2020\, and the Uehara Prize in 2021. He aims to establish and provide patient-specific iPS cells and genetically modified non-human primate models for neuroscience research and to explore the pathogenic mechanisms of neurological/psychiatric disorders. Currently\, he is the leader of the Brain Project in Japan (Brain/MINDS) and the President of The Japanese Society for Regenerative Medicine and The Japanese Society for Neurochemistry. \nThe Aging Brain Initiative is an interdisciplinary effort by MIT focusing on understanding neurodegeneration and discovery efforts to find hallmarks of aging\, both in health and disease.
URL:https://scienceinboston.com/event/aging-brain-seminar-with-hideyuki-okano/
LOCATION:MIT\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220802T120000
DTEND;TZID=America/Toronto:20220802T130000
DTSTAMP:20260427T124410
CREATED:20220729T181012Z
LAST-MODIFIED:20220729T181012Z
UID:27856-1659441600-1659445200@scienceinboston.com
SUMMARY:Aging Brain Seminar with Hideyuki Okano
DESCRIPTION:*This seminar will be held in-person in MIT Building 46\, Room 46-3310 (Picower Seminar Room). If you are attending from outside of MIT\, please email Brittany Greenough at bgreeno@mit.edu to be issued a ticket to gain entry to the building.* \nTalk Title: Modeling neurological diseases using iPS cell technologies and genetically modified non-human primates \nAbstract: The investigation of human neurological/psychiatric disorders have been difficult based on the following reasons: i) Diseases Model Mice do not always recapitulate the pathophysiology of human diseases. ii) Genotype-Phenotype causal relationships are not always clear in many human neurological and psychiatric disorders. iii) It is extremely difficult to investigate what is taking place in vivo at the onset of the disease. iv) The low accessibility to the pathological foci in the human brain. v) The neuronal circuits responsible for the disease phenotypes are mostly unidentified. To overcome these\, we are taking advantage of Take the Advantage of iPS cell technology and genetically modified non-human primates. \nHuman iPS cell (iPSC)-based techniques offer new opportunities for disease modeling and the development of new drugs\, especially for conditions such as neurological and psychiatric diseases in which access to the affected cells and pathogenic sites is limited. So far\, we have established patient-specific iPSCs from more than 40 neurological and psychiatric diseases\, including amyotrophic lateral sclerosis (ALS)\, Alzheimer’s disease\, Parkinson’s disease\, and so on. Today\, I am going to focus on the iPSCs-based investigation of ALS\, which is a devastating neurodegenerative disease characterized by loss of upper motor neurons (MNs) and/or lower MNs (LMNs). Using iPSCs-MNs derived from familial ALS patients with FUS and TDP-43 mutations\, we could identify Ropinirole (ROPI: Already approved as an anti-PD drug with D2R agonist) as a potential anti-ALS Drug which is further being investigated as a clinical trial (ROPALS trial). As a result of the ROPALS trial\, we conclude that ROPI is a safe and effective drug for ALS patients. ROPI significantly suppressed the progression of ALS and prolonged the time to respiratory failure over the 1-year treatment period. This clinical trial proved that iPS cell drug discovery was useful as a new drug screening tool. \nThe common marmoset (Callithrix jacchus) is a small New World primate that has been extensively used in biomedical research models. There is also an increasing interest in common marmoset in Brain Science and as appropriate models for major human brain disorders (Okano\, Annual Rev Neurosci\, 2021). We succeeded in generating the world’s first genetically modified (GM) marmoset with germline transmission by lentiviral mediated transgenesis (Sasaki et al.\, Nature\, 2009) and genome-edited marmosets (GM) (Sato et al.\, Cell Stem Cell\, 2016). I wish to mention our recent data on the generation of transgenic marmoset models of neurodegenerative diseases\, including Parkinson’s disease (PD) which overexpressed the mutant form of a-synuclein using a lentiviral vector. The PD model marmoset showed stage-dependent progression of the disease\, such as sleeping disturbance followed by the motor deficit. In addition\, I will mention a model marmoset of a neurodevelopmental disorder\, the Rett syndrome\, obtained by genome editing of MECP2 gene. Abnormalities in brain structure and function in these marmoset models may accelerate the discovery of disease biomarkers and mechanisms for translation. \nBio: Hideyuki Okano received his M.D. in Physiology from Keio University in 1983. After he obtained a Ph.D. degree in Molecular Biology of Myelin-related genes and myelin deficient mutant mice from Keio University in 1988\, he held a post-doctoral position at Dr. Craig Montell’s Lab at Johns Hopkins University School of Medicine. He was appointed full professor at Tsukuba University School of Medicine in 1994\, Osaka University School of Medicine in 1997\, and returned to Keio University Medical School in 2001 as a full professor of Physiology. Since 2007\, he has been a Dean of Keio University Graduate School of Medicine or a Dean of Keio University School of Medicine. He has been conducting basic research in the field of regenerative medicine including\, neural stem cells and iPS cells\, spinal cord injury\, developmental genetics\, and RNA binding proteins. He has been awarded a number of awards and honors including the Medal with Purple Ribbon in 2009\, the first prize of the 51st Erwin von Bälz Prize in 2014\, the 18th Takamine Memorial Daiichi Sankyo Prize in 2020\, and the Uehara Prize in 2021. He aims to establish and provide patient-specific iPS cells and genetically modified non-human primate models for neuroscience research and to explore the pathogenic mechanisms of neurological/psychiatric disorders. Currently\, he is the leader of the Brain Project in Japan (Brain/MINDS) and the President of The Japanese Society for Regenerative Medicine and The Japanese Society for Neurochemistry. \nThe Aging Brain Initiative is an interdisciplinary effort by MIT focusing on understanding neurodegeneration and discovery efforts to find hallmarks of aging\, both in health and disease.
URL:https://scienceinboston.com/event/aging-brain-seminar-with-hideyuki-okano-2/
LOCATION:MIT\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220811T170000
DTEND;TZID=America/Toronto:20220811T190000
DTSTAMP:20260427T124410
CREATED:20220705T172603Z
LAST-MODIFIED:20220705T172849Z
UID:20672-1660237200-1660244400@scienceinboston.com
SUMMARY:STAT Locals
DESCRIPTION:STAT Locals are free in-person meet ups hosted by STAT. STAT Locals proudly have no programming; they are free happy hour events\, produced by STAT\, meant to help spark new connections and collaborations within the life science communities we report on. \nAugust 11: STAT Locals for the biotech community in Greater Boston (Boston & Cambridge).
URL:https://scienceinboston.com/event/stat-locals/
LOCATION:Cambridge Brewing Co.\, Kendall Square\, 1 Kendall Square\, Bldg 100\, Cambridge\, MA\, 02139\, United States
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2022/07/Logo-on-light-1.png
ORGANIZER;CN="STAT News":MAILTO:stat.community@statnews.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220811T170000
DTEND;TZID=America/Toronto:20220811T190000
DTSTAMP:20260427T124410
CREATED:20220705T172603Z
LAST-MODIFIED:20220705T172603Z
UID:27852-1660237200-1660244400@scienceinboston.com
SUMMARY:STAT Locals
DESCRIPTION:STAT Locals are free in-person meet ups hosted by STAT. STAT Locals proudly have no programming; they are free happy hour events\, produced by STAT\, meant to help spark new connections and collaborations within the life science communities we report on. \nAugust 11: STAT Locals for the biotech community in Greater Boston (Boston & Cambridge).
URL:https://scienceinboston.com/event/stat-locals-2/
LOCATION:Cambridge Brewing Co.\, Kendall Square\, 1 Kendall Square\, Bldg 100\, Cambridge\, MA\, 02139\, United States
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2022/07/Logo-on-light-1.png
ORGANIZER;CN="STAT News":MAILTO:stat.community@statnews.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220818T160000
DTEND;TZID=America/New_York:20220818T183000
DTSTAMP:20260427T124410
CREATED:20220805T222328Z
LAST-MODIFIED:20220805T222328Z
UID:21079-1660838400-1660847400@scienceinboston.com
SUMMARY:Bits in Bio @ Vertex
DESCRIPTION:Vertex is excited to host the next Bits in Bio meetup on their expanded terrace with a phenomenal seaport view! Come catch up and network with the Boston Bits in Bio community\, including engineers and scientists from Vertex who are eager to share how they are creating a cutting-edge technology environment to enable science at scale across the drug discovery pipeline. Food and drinks provided. \nLearn more about Vertex and open roles here: \n\nhttps://www.vrtx.com\nhttps://vrtx.wd5.myworkdayjobs.com/Vertex_Careers/job/Boston-MA/Computational-Chemistry-Senior-Principal-Research-Scientist–Software-Development-_REQ-15166\nhttps://vrtx.wd5.myworkdayjobs.com/Vertex_Careers/job/Boston-MA/Senior-Principal-Software-Engineer–Fullstack-_REQ-15192-1\n\nNote: All attendees must bring government issue ID\, and be vaccinated\, in order to enter the building.
URL:https://scienceinboston.com/event/bits-in-bio-vertex/
LOCATION:Vertex Pharmaceuticals\, 11 Fan Pier Boulevard\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220818T160000
DTEND;TZID=America/New_York:20220818T183000
DTSTAMP:20260427T124410
CREATED:20220805T222328Z
LAST-MODIFIED:20220805T222328Z
UID:27857-1660838400-1660847400@scienceinboston.com
SUMMARY:Bits in Bio @ Vertex
DESCRIPTION:Vertex is excited to host the next Bits in Bio meetup on their expanded terrace with a phenomenal seaport view! Come catch up and network with the Boston Bits in Bio community\, including engineers and scientists from Vertex who are eager to share how they are creating a cutting-edge technology environment to enable science at scale across the drug discovery pipeline. Food and drinks provided. \nLearn more about Vertex and open roles here: \n\nhttps://www.vrtx.com\nhttps://vrtx.wd5.myworkdayjobs.com/Vertex_Careers/job/Boston-MA/Computational-Chemistry-Senior-Principal-Research-Scientist–Software-Development-_REQ-15166\nhttps://vrtx.wd5.myworkdayjobs.com/Vertex_Careers/job/Boston-MA/Senior-Principal-Software-Engineer–Fullstack-_REQ-15192-1\n\nNote: All attendees must bring government issue ID\, and be vaccinated\, in order to enter the building.
URL:https://scienceinboston.com/event/bits-in-bio-vertex-2/
LOCATION:Vertex Pharmaceuticals\, 11 Fan Pier Boulevard\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220908T170000
DTEND;TZID=America/Toronto:20220908T180000
DTSTAMP:20260427T124410
CREATED:20220830T165932Z
LAST-MODIFIED:20220830T165932Z
UID:21417-1662656400-1662660000@scienceinboston.com
SUMMARY:Biomedical Informatics Entrepreneurs Salon: Lovina McMurchy\, Movac Capital
DESCRIPTION:A monthly conversation about medicine\, biology\, computers\, and entrepreneurship. \n\n\nAbout this event\n\n\n\nHosted by Harvard Office of Technology Development and the HMS Dept. of Biomedical Informatics. Open to all. \nFeatured speaker: \nLovina McMurchy\, General Partner at Movac Capital and Edmund Hillary Fellow. \nLovina McMurchy is a General Partner at an international Venture Capital Fund\, Movac Capital and an Edmund Hillary Fellow\, a program for exceptional entrepreneurs and investors working on global impact projects from Aotearoa/New Zealand. \nShe came to VC as a career transition after spending 20 years working for global technology companies based in the US. Her operating experience spans across product development\, go-to-market and P&L management. Most recently she was a general manager of Growth for Alexa Shopping at Amazon and before that pioneered Amazon’s move into 3rd party subscription services. She held several senior leadership roles at Microsoft including being a senior executive at Skype and a tour of duty as Chief Marketing Officer for Microsoft Latin America. At Starbucks she launched several technology innovation services including the in-store wifi service and Starbucks first “order by phone” offering. \nShe holds an MBA from Harvard Business school and a Masters in Mathematics and Statistics from the University of Auckland. She currently lives in New Zealand with her husband and children.
URL:https://scienceinboston.com/event/biomedical-informatics-entrepreneurs-salon-lovina-mcmurchy-movac-capital/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220908T170000
DTEND;TZID=America/Toronto:20220908T180000
DTSTAMP:20260427T124410
CREATED:20220830T165932Z
LAST-MODIFIED:20220830T165932Z
UID:27868-1662656400-1662660000@scienceinboston.com
SUMMARY:Biomedical Informatics Entrepreneurs Salon: Lovina McMurchy\, Movac Capital
DESCRIPTION:A monthly conversation about medicine\, biology\, computers\, and entrepreneurship. \n\n\nAbout this event\n\n\n\nHosted by Harvard Office of Technology Development and the HMS Dept. of Biomedical Informatics. Open to all. \nFeatured speaker: \nLovina McMurchy\, General Partner at Movac Capital and Edmund Hillary Fellow. \nLovina McMurchy is a General Partner at an international Venture Capital Fund\, Movac Capital and an Edmund Hillary Fellow\, a program for exceptional entrepreneurs and investors working on global impact projects from Aotearoa/New Zealand. \nShe came to VC as a career transition after spending 20 years working for global technology companies based in the US. Her operating experience spans across product development\, go-to-market and P&L management. Most recently she was a general manager of Growth for Alexa Shopping at Amazon and before that pioneered Amazon’s move into 3rd party subscription services. She held several senior leadership roles at Microsoft including being a senior executive at Skype and a tour of duty as Chief Marketing Officer for Microsoft Latin America. At Starbucks she launched several technology innovation services including the in-store wifi service and Starbucks first “order by phone” offering. \nShe holds an MBA from Harvard Business school and a Masters in Mathematics and Statistics from the University of Auckland. She currently lives in New Zealand with her husband and children.
URL:https://scienceinboston.com/event/biomedical-informatics-entrepreneurs-salon-lovina-mcmurchy-movac-capital-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220913T120000
DTEND;TZID=America/Toronto:20220913T130000
DTSTAMP:20260427T124410
CREATED:20220829T055457Z
LAST-MODIFIED:20220829T055457Z
UID:21369-1663070400-1663074000@scienceinboston.com
SUMMARY:Finding Funding for Alzheimer’s Disease Research: Meet BrightFocus Foundation
DESCRIPTION:Are you looking for funding to advance your research on Alzheimer’s disease (AD) and related dementias (ADRD)? Join us for this virtual event to learn about BrightFocus Foundation\, a leading global nonprofit funder of innovative basic\, translational\, and clinical research to accelerate understanding\, prevention\, treatment\, and cures for AD and ADRD. Each year\, the foundation’s Alzheimer’s Disease Research program funds nearly 150 scientific research projects worldwide led by both postdocs and independent faculty members\, with a focus on early-career scientists. (This year’s application deadline is November 1st.) Dr. Sharyn Rossi\, PhD\, Director of Scientific Programs in Neuroscience at the foundation\, will lead a discussion with BrightFocus Foundation grantees and Boston University School of Medicine faculty members Ben Wolozin\, MD\, PhD\, and Manveen Sethi\, PhD.
URL:https://scienceinboston.com/event/finding-funding-for-alzheimers-disease-research-meet-brightfocus-foundation/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220913T120000
DTEND;TZID=America/Toronto:20220913T130000
DTSTAMP:20260427T124410
CREATED:20220829T055457Z
LAST-MODIFIED:20220829T055457Z
UID:27863-1663070400-1663074000@scienceinboston.com
SUMMARY:Finding Funding for Alzheimer’s Disease Research: Meet BrightFocus Foundation
DESCRIPTION:Are you looking for funding to advance your research on Alzheimer’s disease (AD) and related dementias (ADRD)? Join us for this virtual event to learn about BrightFocus Foundation\, a leading global nonprofit funder of innovative basic\, translational\, and clinical research to accelerate understanding\, prevention\, treatment\, and cures for AD and ADRD. Each year\, the foundation’s Alzheimer’s Disease Research program funds nearly 150 scientific research projects worldwide led by both postdocs and independent faculty members\, with a focus on early-career scientists. (This year’s application deadline is November 1st.) Dr. Sharyn Rossi\, PhD\, Director of Scientific Programs in Neuroscience at the foundation\, will lead a discussion with BrightFocus Foundation grantees and Boston University School of Medicine faculty members Ben Wolozin\, MD\, PhD\, and Manveen Sethi\, PhD.
URL:https://scienceinboston.com/event/finding-funding-for-alzheimers-disease-research-meet-brightfocus-foundation-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220915T080000
DTEND;TZID=America/Toronto:20220916T170000
DTSTAMP:20260427T124410
CREATED:20220620T054003Z
LAST-MODIFIED:20220808T204248Z
UID:20439-1663228800-1663347600@scienceinboston.com
SUMMARY:Forsyth Dentech 2022
DESCRIPTION:Forsyth dentech is the leading oral health technology innovation conference convening thought leaders from research\, industry\, academia\, and venture capital. This annual event aims to accelerate innovation and launch new ventures in the oral health space. \nThe event will host a live presentation session where selected presenters will have the stage to showcase their exciting new technology or pitch their business cases to conference attendees\, including Forsyth’s partners in the oral health innovation ecosystem (i.e.\, angels\, venture capitalists and industry partners). \nThe application period for presentation submissions is now open and closes on August 1\, 2022 at 11:59 p.m. EDT. Presenters will be selected on a rolling basis. Presenters will have opportunities to engage with Forsyth’s Technology Development team and its ecosystem partners to deepen their networks\, fine-tune their business plans and explore potential seed funding. \nThis is a hybrid event. Participants may attend virtually or in-person. On-site space is limited. \nLearn more and register.
URL:https://scienceinboston.com/event/forsyth-dentech-2022/
LOCATION:Forsyth Institute and Online\, 245 First Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220915T080000
DTEND;TZID=America/Toronto:20220916T170000
DTSTAMP:20260427T124410
CREATED:20220620T054003Z
LAST-MODIFIED:20220620T054003Z
UID:27843-1663228800-1663347600@scienceinboston.com
SUMMARY:Forsyth Dentech 2022
DESCRIPTION:Forsyth dentech is the leading oral health technology innovation conference convening thought leaders from research\, industry\, academia\, and venture capital. This annual event aims to accelerate innovation and launch new ventures in the oral health space. \nThe event will host a live presentation session where selected presenters will have the stage to showcase their exciting new technology or pitch their business cases to conference attendees\, including Forsyth’s partners in the oral health innovation ecosystem (i.e.\, angels\, venture capitalists and industry partners). \nThe application period for presentation submissions is now open and closes on August 1\, 2022 at 11:59 p.m. EDT. Presenters will be selected on a rolling basis. Presenters will have opportunities to engage with Forsyth’s Technology Development team and its ecosystem partners to deepen their networks\, fine-tune their business plans and explore potential seed funding. \nThis is a hybrid event. Participants may attend virtually or in-person. On-site space is limited. \nLearn more and register.
URL:https://scienceinboston.com/event/forsyth-dentech-2022-2/
LOCATION:Forsyth Institute and Online\, 245 First Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220915T123000
DTEND;TZID=America/Toronto:20220915T173000
DTSTAMP:20260427T124410
CREATED:20220829T060043Z
LAST-MODIFIED:20220829T060043Z
UID:21375-1663245000-1663263000@scienceinboston.com
SUMMARY:2022 Patient Advocacy Summit
DESCRIPTION:MassBio’s Patient Advocacy Summit showcases the best practices and cutting-edge examples of how life sciences companies can more fully incorporate the patient voice into the work they do throughout the drug development cycle. This year’s event theme is “Supporting the Patient from all Angles: For-Profit\, Non-Profit\, and Government organizations.” Join the patient advocacy community as we explore this topic with keynote addresses\, a panel discussion\, and a professional development workshop for patient advocates. Don’t miss one of our most popular conferences.
URL:https://scienceinboston.com/event/2022-patient-advocacy-summit/
LOCATION:MassBioHub & Online\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220915T123000
DTEND;TZID=America/Toronto:20220915T173000
DTSTAMP:20260427T124410
CREATED:20220829T060043Z
LAST-MODIFIED:20220829T060043Z
UID:27865-1663245000-1663263000@scienceinboston.com
SUMMARY:2022 Patient Advocacy Summit
DESCRIPTION:MassBio’s Patient Advocacy Summit showcases the best practices and cutting-edge examples of how life sciences companies can more fully incorporate the patient voice into the work they do throughout the drug development cycle. This year’s event theme is “Supporting the Patient from all Angles: For-Profit\, Non-Profit\, and Government organizations.” Join the patient advocacy community as we explore this topic with keynote addresses\, a panel discussion\, and a professional development workshop for patient advocates. Don’t miss one of our most popular conferences.
URL:https://scienceinboston.com/event/2022-patient-advocacy-summit-2/
LOCATION:MassBioHub & Online\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220920T100000
DTEND;TZID=America/Toronto:20220920T161500
DTSTAMP:20260427T124410
CREATED:20220718T184733Z
LAST-MODIFIED:20220718T184759Z
UID:20862-1663668000-1663690500@scienceinboston.com
SUMMARY:Precision Medicine 2022: The New "Normal"?
DESCRIPTION:This year our annual conference will focus on novel applications as well as long-standing challenges of genetic testing\, a measurement modality central to precision medicine.* While the clinical applications of genetic testing have broadened from a single gene focus to increasingly available whole genome sequencing and genome-wide risk scores\, there remains much confusion around the appropriate evidentiary standards for their use in clinical practice and in R&D. This conference will provide a platform to discuss foundational questions such as the nature of “normal” genetic variation in the context of both established forms of testing and cutting-edge technology. To achieve these goals\, we will convene expert scientists from academia and industry who are developing new applications and technologies of genetic testing as well as laboratory directors and individuals responsible for guidelines on variant interpretation. We will frame these discussions around how best to improve precision medicine for all populations. As we have done in years past\, we will center on elevating the patient voice and building patient engagement.
URL:https://scienceinboston.com/event/precision-medicine-2022-the-new-normal/
LOCATION:Joseph B. Martin Conference Center & Online\, 77 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220920T100000
DTEND;TZID=America/Toronto:20220920T161500
DTSTAMP:20260427T124410
CREATED:20220718T184733Z
LAST-MODIFIED:20220718T184733Z
UID:27853-1663668000-1663690500@scienceinboston.com
SUMMARY:Precision Medicine 2022: The New "Normal"?
DESCRIPTION:This year our annual conference will focus on novel applications as well as long-standing challenges of genetic testing\, a measurement modality central to precision medicine.* While the clinical applications of genetic testing have broadened from a single gene focus to increasingly available whole genome sequencing and genome-wide risk scores\, there remains much confusion around the appropriate evidentiary standards for their use in clinical practice and in R&D. This conference will provide a platform to discuss foundational questions such as the nature of “normal” genetic variation in the context of both established forms of testing and cutting-edge technology. To achieve these goals\, we will convene expert scientists from academia and industry who are developing new applications and technologies of genetic testing as well as laboratory directors and individuals responsible for guidelines on variant interpretation. We will frame these discussions around how best to improve precision medicine for all populations. As we have done in years past\, we will center on elevating the patient voice and building patient engagement.
URL:https://scienceinboston.com/event/precision-medicine-2022-the-new-normal-2/
LOCATION:Joseph B. Martin Conference Center & Online\, 77 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220920T143000
DTEND;TZID=America/Toronto:20220920T171500
DTSTAMP:20260427T124410
CREATED:20220830T165744Z
LAST-MODIFIED:20220830T165744Z
UID:21414-1663684200-1663694100@scienceinboston.com
SUMMARY:Women in Medicine and Science Symposium
DESCRIPTION:The eleventh annual Women in Medicine & Science Symposium (WMSS) will be held on Tuesday\, September\, 20\, 2022.\n\n\n\n\n\nThe Women in Medicine and Science Symposium will highlight the achievements of women faculty and trainees at Brigham and Women’s and Mass General Hospitals. The Symposium will celebrate the accomplishments of women faculty and trainees across different disciplines – including basic science\, clinical and translational research\, clinical innovation\, and education – with the goal of strengthening the BWH\, MGH and MGB community.
URL:https://scienceinboston.com/event/women-in-medicine-and-science-symposium/
LOCATION:Brigham and Women’s Hospital\, 75 Francis Street\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220920T143000
DTEND;TZID=America/Toronto:20220920T171500
DTSTAMP:20260427T124410
CREATED:20220830T165744Z
LAST-MODIFIED:20220830T165744Z
UID:27867-1663684200-1663694100@scienceinboston.com
SUMMARY:Women in Medicine and Science Symposium
DESCRIPTION:The eleventh annual Women in Medicine & Science Symposium (WMSS) will be held on Tuesday\, September\, 20\, 2022.\n\n\n\n\n\nThe Women in Medicine and Science Symposium will highlight the achievements of women faculty and trainees at Brigham and Women’s and Mass General Hospitals. The Symposium will celebrate the accomplishments of women faculty and trainees across different disciplines – including basic science\, clinical and translational research\, clinical innovation\, and education – with the goal of strengthening the BWH\, MGH and MGB community.
URL:https://scienceinboston.com/event/women-in-medicine-and-science-symposium-2/
LOCATION:Brigham and Women’s Hospital\, 75 Francis Street\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220920T173000
DTEND;TZID=America/Toronto:20220920T183000
DTSTAMP:20260427T124410
CREATED:20220818T160434Z
LAST-MODIFIED:20220818T160434Z
UID:21259-1663695000-1663698600@scienceinboston.com
SUMMARY:Using Chemical and Biomedical Engineering to Advance Biomedicine
DESCRIPTION:Join Ruth Lehmann\, Director\, Whitehead Institute\, for a conversation with scientist and inventor\, Robert Langer\, MIT Institute Professor\, on how chemical and biological engineering will impact human health.
URL:https://scienceinboston.com/event/using-chemical-and-biomedical-engineering-to-advance-biomedicine/
LOCATION:Whitehead Institute for Biomedical Research\, 455 Main Street\, Cambridge\, MA\, 02142\, United States
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2022/08/DD_Slide_2022_09_Langer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220920T173000
DTEND;TZID=America/Toronto:20220920T183000
DTSTAMP:20260427T124410
CREATED:20220818T160434Z
LAST-MODIFIED:20220818T160434Z
UID:27861-1663695000-1663698600@scienceinboston.com
SUMMARY:Using Chemical and Biomedical Engineering to Advance Biomedicine
DESCRIPTION:Join Ruth Lehmann\, Director\, Whitehead Institute\, for a conversation with scientist and inventor\, Robert Langer\, MIT Institute Professor\, on how chemical and biological engineering will impact human health.
URL:https://scienceinboston.com/event/using-chemical-and-biomedical-engineering-to-advance-biomedicine-2/
LOCATION:Whitehead Institute for Biomedical Research\, 455 Main Street\, Cambridge\, MA\, 02142\, United States
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2022/08/DD_Slide_2022_09_Langer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220921T153000
DTEND;TZID=America/Toronto:20220921T173000
DTSTAMP:20260427T124410
CREATED:20220829T055718Z
LAST-MODIFIED:20220829T055718Z
UID:21372-1663774200-1663781400@scienceinboston.com
SUMMARY:Research on Tap: Neuromonitoring Brain Health and Recovery
DESCRIPTION:This Research on Tap event will highlight the interdisciplinary work at Boston University that integrates health data\, both brain data and behavioral data\, with state of the art computing methods to develop models for precision medicine in neurological disease (e.g.\, stroke\, dementia\, traumatic brain injury).
URL:https://scienceinboston.com/event/research-on-tap-neuromonitoring-brain-health-and-recovery/
LOCATION:Rajen Kilachand Center for Integrated Life Sciences and Engineering\, 610 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220921T153000
DTEND;TZID=America/Toronto:20220921T173000
DTSTAMP:20260427T124410
CREATED:20220829T055718Z
LAST-MODIFIED:20220829T055718Z
UID:27864-1663774200-1663781400@scienceinboston.com
SUMMARY:Research on Tap: Neuromonitoring Brain Health and Recovery
DESCRIPTION:This Research on Tap event will highlight the interdisciplinary work at Boston University that integrates health data\, both brain data and behavioral data\, with state of the art computing methods to develop models for precision medicine in neurological disease (e.g.\, stroke\, dementia\, traumatic brain injury).
URL:https://scienceinboston.com/event/research-on-tap-neuromonitoring-brain-health-and-recovery-2/
LOCATION:Rajen Kilachand Center for Integrated Life Sciences and Engineering\, 610 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
END:VCALENDAR